Vascular Diseases

Subtype terms (46)

More specific conditions that are subtypes of Vascular Diseases in the MeSH hierarchy.

• Aneurysm

  39 drugs (35 approved, 4 experimental)

• Aneurysm, False
• Angiodysplasia

  4 drugs approved

• Angioedema

  30 drugs (22 approved, 8 experimental)

• Angiomatosis

  3 drugs approved

• Aortic Diseases

  35 drugs (29 approved, 6 experimental)

• Arterial Occlusive Diseases

  111 drugs (79 approved, 32 experimental)

• Arteriovenous Malformations

  15 drugs (13 approved, 2 experimental)

• Capillary Leak Syndrome

  2 drugs approved

• Cerebrovascular Disorders

  83 drugs (58 approved, 25 experimental)

• Colitis, Ischemic

  1 drug experimental

• Compartment Syndromes
• Diabetic Angiopathies

  9 drugs (6 approved, 3 experimental)

• Embolism and Thrombosis

  11 drugs (10 approved, 1 experimental)

• Hand-Arm Vibration Syndrome
• Hemorrhoids

  65 drugs (38 approved, 27 experimental)

• Hemostatic Disorders

  7 drugs (2 approved, 5 experimental)

• Hepatic Veno-Occlusive Disease

  3 drugs approved

• Hyperemia

  13 drugs (9 approved, 4 experimental)

• Hypertension

  637 drugs (322 approved, 315 experimental)

• Hypotension

  141 drugs (105 approved, 36 experimental)

• Mesenteric Ischemia

  6 drugs (5 approved, 1 experimental)

• Myocardial Ischemia

  203 drugs (135 approved, 68 experimental)

• Optic Neuropathy, Ischemic

  24 drugs (19 approved, 5 experimental)

• Peliosis Hepatis
• Penetrating Atherosclerotic Ulcer
• Peripheral Vascular Diseases

  79 drugs (42 approved, 37 experimental)

• Prehypertension

  48 drugs (31 approved, 17 experimental)

• Pulmonary Veno-Occlusive Disease

  3 drugs approved

• Reperfusion Injury

  88 drugs (71 approved, 17 experimental)

• Retinal Vein Occlusion

  46 drugs (30 approved, 16 experimental)

• Scimitar Syndrome
• Spinal Cord Vascular Diseases
• Splenic Infarction
• Stenosis, Pulmonary Vein

  2 drugs approved

• Superior Vena Cava Syndrome
• Telangiectasis

  8 drugs (6 approved, 2 experimental)

• Thoracic Outlet Syndrome

  4 drugs approved

• Varicocele

  5 drugs (4 approved, 1 experimental)

• Varicose Veins

  28 drugs (18 approved, 10 experimental)

• Vascular Fistula
• Vascular Neoplasms

  1 drug approved

• Vascular System Injuries

  10 drugs (5 approved, 5 experimental)

• Vasculitis

  50 drugs (32 approved, 18 experimental)

• Vasoplegia

  13 drugs (12 approved, 1 experimental)

• Venous Insufficiency

  26 drugs (7 approved, 19 experimental)

Drugs by status

Organizations